SALT LAKE CITY, April 21, 2008 (PRIME NEWSWIRE) -- BSD Medical
Corporation (AMEX:
BSM -
News) announced today that it will begin
trading on the NASDAQ Stock Market LLC(r) effective Tuesday,
April 22, 2008. The company is switching the listing of
its common stock from the American Stock Exchange to the
NASDAQ stock market, and on April 22 it will open trading
under the symbol NASDAQ:BSDM, replacing its former symbol
AMEX:BSM.
BSD Medical believes that the electronic multiple market
maker structure provided by NASDAQ will enhance the exposure
and liquidity of its shares, while at the same time providing
investors with the best prices, the fastest execution and
lower cost per trade.
The company's objective is also to provide added visibility
to its investors. NASDAQ provides the largest liquidity
pool, and in 2007 became the largest U.S. stock exchange.
NASDAQ is recognized as the home to the world's leading
brands, and BSD Medical is pleased to join the NASDAQ Stock
Market.
About BSD Medical Corporation
BSD Medical is a leading developer of medical systems used
to deliver precision-focused RF or microwave energy for
the treatment of cancer and other diseases and conditions.
BSD Medical's cancer therapy systems have been designed
to kill cancer through heat alone, or as companion therapies
to improve the combined results when used along with other
treatments. As a biotechnology company, the ``BSD'' in its
name represents the company's specialty in ``bio-systems
design.'' For further information visit BSD Medical's website
at http://www.BSDMedical.com.
About NASDAQ
NASDAQ(r) is the largest U.S. electronic stock market. With
approximately 3,200 companies, it lists more companies and,
on average, its systems trade more shares per day than any
other U.S. market. NASDAQ is home to companies that are
leaders across all areas of business including technology,
retail, communications, financial services, transportation,
media and biotechnology.
Statements contained in this press release that are not
historical facts are forward-looking statements, as defined
in the Private Securities Litigation Reform Act of 1995.
All forward-looking statements are subject to risks and
uncertainties detailed in the Company's filings with the
Securities and Exchange Commission. These forward-looking
statements speak only as of the date on which such statements
are made, and the Company undertakes no obligation to update
such statements to reflect events or circumstances arising
after such date.